Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Justification Study of GSK Malaria Vaccine 257049
NCT00443131Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2007
- Primary completion
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of RTS,S in malaria, sponsored by GSK. Started Mar 2007; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00443131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443131.